|
Affiliation |
Faculty of Medicine School of Medicine Department of Pathology, Pathophysiology |
|
Title |
Professor |
|
External Link |
|
YAMASHITA Atsushi
|
|
|
Degree 【 display / non-display 】
-
medical doctor ( 2004.3 University of Miyazaki )
-
学士（医学） ( 1997.3 宮崎大学 )
Research Areas 【 display / non-display 】
-
Life Science / Human pathology / PATHOLOGY
Papers 【 display / non-display 】
-
Yamashita A., Oda T., Aman M., Wakasa T., Gi T., Ide R., Todo Y., Tamura N., Sato Y., Itoh H., Asada Y.
BJOG: An International Journal of Obstetrics and Gynaecology 2023
Authorship：Lead author, Corresponding author Language：English Publishing type：Research paper (scientific journal) Publisher：BJOG: An International Journal of Obstetrics and Gynaecology
Objective: To identify pulmonary/uterine thrombus formation in amniotic fluid embolism (AFE). Design: Retrospective, observational. Setting: Nationwide. Population: Eleven autopsy cases of AFE and control cases. Methods: We assessed pulmonary and uterine thrombus formation and thrombus area in AFE and pulmonary thromboembolism (PTE) as a control. The area of platelet glycoprotein IIb/IIIa, fibrin, neutrophil elastase, citrullinated histone H3 (a neutrophil extracellular trap marker) and mast cell chymase immunopositivity was measured in 90 pulmonary emboli, 15 uterine thrombi and 14 PTE. Main outcome measures: Pathological evidence of thrombus formation and its components in AFE. Results: Amniotic fluid embolism lung showed massive thrombus formation, with or without amniotic emboli in small pulmonary arteries and capillaries. The median pulmonary thrombus size in AFE (median, 0.012 mm2; P < 0.0001) was significantly smaller than that of uterine thrombus in AFE (0.61 mm2) or PTE (29 mm2). The median area of glycoprotein IIb/IIIa immunopositivity in pulmonary thrombi in AFE (39%; P < 0.01) was significantly larger than that of uterine thrombi in AFE (23%) and PTE (15%). The median area of fibrin (0%; P < 0.001) and citrullinated histone H3 (0%; P < 0.01) immunopositivity in pulmonary thrombi in AFE was significantly smaller than in uterine thrombi (fibrin: 26%; citrullinated histone H3: 1.1%) and PTE (fibrin: 42%; citrullinated histone H3: 0.4%). No mast cells were identified in pulmonary thrombi. Conclusions: Amniotic fluid may induce distinct thrombus formation in the uterus and lung. Pulmonary and uterine thrombi formation may contribute to cardiorespiratory collapse and/or consumptive coagulopathy in AFE.
-
Histopathological Features of Cancer-Associated Venous Thromboembolism: Presence of Intrathrombus Cancer Cells and Prothrombotic Factors. Reviewed
Gi T, Kuwahara A, Yamashita A, Matsuda S, Maekawa K, Moriguchi-Goto S, Sato Y, Asada Y
Arteriosclerosis, thrombosis, and vascular biology 2022.11
Authorship：Corresponding author Language：English Publishing type：Research paper (scientific journal)
-
Otani T., Moriguchi-Goto S., Nishihira K., Oguri N., Shibata Y., Matsuura Y., Kodama T., Asada Y., Hatakeyama K., Yamashita A.
Thrombosis Research 234 134 - 141 2024.2
Language：English Publishing type：Research paper (scientific journal) Publisher：Thrombosis Research
Aim: To investigate the role of pentraxin 3 (PTX3) in atherosclerotic disease progression and plaque destabilization, as well as in coronary restenosis after directional coronary atherectomy (DCA). Materials and methods: PTX3 contents of early and advanced atherosclerotic lesions of the aorta obtained at autopsy were determined by ELISA and Western blot. Also, coronary plaques of patients with acute coronary syndrome (ACS) or stable angina pectoris (SAP) obtained by DCA were analyzed by immunohistochemistry for PTX3. The effects of PTX3 on smooth muscle cells (SMCs) and thrombogenesis were investigated with cultured human coronary artery SMCs and a flow chamber system, respectively. Results: Advanced atherosclerotic lesions contained a significantly larger amount of PTX3 than early lesions (ELISA: 9.96 ± 2.77 ng/100 mg tissue, n = 8 vs 0.24 ± 0.18 ng/100 mg tissue, n = 6, P = 0.0097). Also, ACS plaques contained a significantly larger amount of PTX3 than SAP plaques (PTX3 immunohistochemistry–positive area percentage: 2.88 ± 0.53 %, n = 22 vs 0.67 ± 0.27 %, n = 23, P = 0.0009). Curiously, the patients who would remain free of post-DCA restenosis (n = 19) had plaques with a significantly higher PTX3 immunohistochemistry–positive area percentage than those who would develop restenosis (n = 12) (2.32 ± 0.49 % vs 0.49 ± 0.17 %, P = 0.002). In the mechanistic part of the study, PTX3 inhibited SMC proliferation and migration. PTX3 also inhibited platelet thrombus formation in the condition simulating arterial blood flow. Conclusions: PTX3 is increased in advanced (vs early) atherosclerotic lesions and unstable (vs stable) coronary plaques. The inhibitory effects of PTX3 on SMCs and thrombogenesis suggest that intraplaque PTX3 might have atheroprotective effects.
-
Shimazu H., Matsuura Y., Moribayashi K., Gi T., Suiko Y., Tanaka H., Komaki S., Ishikawa T., Yamashita A., Kaikita K.
JACC: Case Reports 24 102017 2023.10
Language：English Publishing type：Research paper (scientific journal) Publisher：JACC: Case Reports
Immune thrombocytopenia (ITP) carries bleeding and thrombotic risks; however, thromboses associated with ITP have not been histologically examined. This report presents optical coherence tomography images of the culprit lesion and histology of coronary aspirates in very late stent thrombosis complicating severe ITP, providing evidence of platelet-rich thrombus formation. (Level of Difficulty: Advanced.)
-
Magnetic Resonance Imaging of Cancer-Associated Deep Vein Thrombus in a Patient With Gastric Cancer Reviewed
Gi Toshihiro, Kuroiwa Yasuyoshi, Kihara Yasushi, Miyaushiro Sae, Yamashita Atsushi
Circulation Reports advpub ( 0 ) 2023.4
Authorship：Corresponding author Language：English Publishing type：Case report Publisher：一般社団法人 日本循環器学会
Books 【 display / non-display 】
-
モデル動物の作製と利用. 循環器疾患
山下 篤、大栗伸行、浅田祐士郎（ Role： Joint author , 深部静脈血栓モデル）
エル・アイ・シー. 2021.9
Language：Japanese Book type：Scholarly book
-
モデル動物の作製と利用. 循環器疾患
山下 篤、魏 峻洸、浅田祐士郎（ Role： Joint author , ウサギ反復傷害血栓モデル）
エル・アイ・シー 2021.9
Language：Japanese Book type：Scholarly book
-
New Textbook of Clinical Phlebology
（ Role： Contributor）
2019.10
Language：Japanese
-
Thrombosis, atherosclerosis and atherothrombosis: New insights and experimental protocols
Yamashita A, Asada Y（ Role： Joint author）
Intech 2015.12
Language：English Book type：Scholarly book
-
Traditional and novel risk factors in atherothrombosis
Atsushi Yamashita, Yujiro Asada（ Role： Joint author）
Intech 2012.4
Language：English Book type：Scholarly book
MISC 【 display / non-display 】
-
Maekawa K., Nagayasu E., Hata Y., Hanamure F., Maruyama H., Yamashita A.
Pathology International 73 ( 8 ) 373 - 376 2023.8
Language：English Publishing type：Rapid communication, short report, research note, etc. (scientific journal) Publisher：Pathology International
DOI： 10.1111/pin.13352
-
冠動脈血栓の病理 Invited
山下 篤、西平賢作、浅田祐士郎
病理と臨床 39 ( 11 ) 1099 - 1105 2021.11
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (trade magazine, newspaper, online media)
-
ウサギ：ヒトの動脈硬化をウサギで再現 Invited
山下 篤、浅田祐士郎
医学のあゆみ 279 ( 2 ) 169 - 175 2021.10
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (trade magazine, newspaper, online media)
-
脳梗塞の血管・血栓病理と血栓の形成機序 Invited
山下 篤、浅田祐士郎
Brain and Nerve 73 ( 9 ) 965 - 974 2021.9
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (trade magazine, newspaper, online media)
-
アテローム血栓症における血栓形成機序はどこまでわかったのか？ Invited
山下 篤、浅田祐士郎
Heart View 25 ( 1 ) 32 - 38 2021.1
Language：Japanese Publishing type：Article, review, commentary, editorial, etc. (trade magazine, newspaper, online media)
Presentations 【 display / non-display 】
-
血栓症の発症に繋がる血栓の発生および成長機序の解明
山下 篤
第67回日本病理学会秋期特別総会 2021.11.4
Event date： 2021.11.4 - 2021.11.5
Language：Japanese Presentation type：Oral presentation (invited, special)
-
Detection and safety prevention of deep vein thrombosis Invited International conference
Atsushi Yamashita
The 19th International symposium on atherosclerosis 2021.10.26
Event date： 2021.10.24 - 2021.10.27
Language：English Presentation type：Symposium, workshop panel (nominated)
-
破裂性冠動脈プラークの病理とモデル動物のPETイメージング Invited
山下 篤
第53回日本動脈硬化学会総会 2021.10.23
Event date： 2021.10.23 - 2021.10.24
Language：Japanese Presentation type：Symposium, workshop panel (nominated)
-
静脈血栓症の病理 Invited
山下 篤
第43回日本血栓止血学会 2021.5.29
Event date： 2021.5.28 - 2021.5.31
Language：Japanese Presentation type：Symposium, workshop panel (nominated)
-
Histopathological features of cancer-associated venous thromboembolism in human International conference
Gi T, Yamashita A, Matsuda S, Sato Y, Asada Y.
ISTH 2020 Virtual Congress,
Event date： 2020.7.13 - 2020.7.14
Language：English Presentation type：Poster presentation
Awards 【 display / non-display 】
-
日本病理学会学術研究賞
2021.11 日本病理学会 血栓症の発症に繋がる血栓の発生および成長機序の解明
山下 篤
Award type：Award from Japanese society, conference, symposium, etc.
-
第４回ウサギバイオサイエンス研究会優秀発表賞
2016.8 ウサギバイオサイエンス研究会
山下 篤
Award type：Award from Japanese society, conference, symposium, etc. Country：Japan
-
日本血栓止血学会優秀ポスター賞
2010.4 日本血栓止血学会優秀ポスター賞
山下 篤
Award type：Award from Japanese society, conference, symposium, etc. Country：Japan
-
日本病理学会学術奨励賞
2007.3 日本病理学会
山下 篤
Award type：Award from Japanese society, conference, symposium, etc. Country：Japan
-
日本血栓止血学会学術奨励賞
2005.11 日本血栓止血学会
山下 篤
Award type：Award from Japanese society, conference, symposium, etc. Country：Japan
Grant-in-Aid for Scientific Research 【 display / non-display 】
-
肺血栓塞栓症における非塞栓部肺動脈の変化と静脈血栓由来因子の解明
Grant number：23K06467 2023.04 - 2026.03
独立行政法人日本学術振興会 科学研究費基金 基盤研究（C）
Authorship：Principal investigator
-
薬物送達システムとα線放出核種を組み合わせた革新的な白血病治療法の開発
Grant number：23H02862 2023.04 - 2026.03
独立行政法人日本学術振興会 科学研究費補助金 基盤研究（B）
Authorship：Coinvestigator(s)
-
妊産婦死亡の主因である羊水塞栓症における血栓性病態の解明
Grant number：22K06961 2022.04 - 2025.03
独立行政法人日本学術振興会 科学研究費補助金 基盤研究(C)
阿萬 紫、
Authorship：Coinvestigator(s)
-
静脈血栓塞栓の質的診断に繋がるDual-energyCTによる血栓の成分解析
Grant number：21K07706 2021.04 - 2025.03
独立行政法人日本学術振興会 科学研究費補助金 基盤研究(C)
古小路 英二、
Authorship：Coinvestigator(s)
-
動脈硬化性血栓症における内因系凝固因子の役割
2016.04 - 2019.03
科学研究費補助金 基盤研究(C)
Authorship：Principal investigator
Other research activities 【 display / non-display 】
-
血栓止血用語集
2012.04 - 2015.12
血栓止血用語集の編集委員